EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LncRNA UCA1 regulates immune micro-environment in cisplatin-induced AKI by miRNA-4498/AKT3 pathway

Peng Hongjun, Lydia Mukanhaire iD, Liu Zhen, Wang Ting, Li Hongye, Zhang Xiaotian, Liu Guangling, Ren Xianguo iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0314654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Peng Hongjun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nanjing Drum Tower Hospital, Affiliated hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Cisplatin, RNA, Long Noncoding, MicroRNAs, Acute Kidney Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An increasing number of studies highlight the significance of long non-coding RNAs (lncRNAs) in the biological process of acute kidney injury (AKI). This study investigates the role and the mechanism of lncRNA UCA1 in cisplatin-induced AKI. Real-time quantitative PCR was used to measure lncRNA UCA1 expression in cisplatin-induced AKI mouse model, showing that lncRNA UCA1 was overexpressed. Knockdown of lncRNA UCA1 by shRNA significantly reduced inflammation caused by cisplatin treatment. A co-culture system demonstrated that lncRNA UCA1 upregulation in T cells induced apoptosis of tubular epithelial cells (TECs). A dual-luciferase reporter assay confirmed that lncRNA UCA1 acts as a miR-4498 sponge, binding to the 3’UTR of AKT3. Flow cytometry and ELISA results showed that reduced inflammation effect induced by lncRNA UCA1 knockdown was reversed by miR-4498 inhibition or AKT3 overexpression. Our findings suggest that lncRNA UCA1 functions as a miR-4498 sponge, upregulating AKT3 expression, and promoting inflammation in cisplatin-induced AKI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinRNA, Long NoncodingMicroRNAsAcute Kidney InjuryProto-Oncogene Proteins c-aktAnimalsMiceMaleApoptosisSignal TransductionMice, Inbred C57BLDisease Models, AnimalEpithelial CellsHumans

Substanzen

CisplatinRNA, Long NoncodingMicroRNAsProto-Oncogene Proteins c-aktAkt3 protein, mouse

Autor:innen und Institutionen

  • Department of Pediatrics, Nanjing Drum Tower Hospital, Affiliated hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
  • Jiangsu Key Laboratory for Biodiversity and Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, Jiangsu, China.
  • Department of Pediatrics, Sir Run Run Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.

ORCID-Profile: Lydia Mukanhaire, Ren Xianguo

Zitieren

APA

Hongjun, P., Mukanhaire, L., Zhen, L., Ting, W., Hongye, L., Xiaotian, Z., Guangling, L., & Xianguo, R. (2025). LncRNA UCA1 regulates immune micro-environment in cisplatin-induced AKI by miRNA-4498/AKT3 pathway. PLOS ONE. https://doi.org/10.1371/journal.pone.0314654

Vancouver

Hongjun P, Mukanhaire L, Zhen L, Ting W, Hongye L, Xiaotian Z, et al. LncRNA UCA1 regulates immune micro-environment in cisplatin-induced AKI by miRNA-4498/AKT3 pathway. PLOS ONE. 2025. doi:10.1371/journal.pone.0314654

BibTeX
@article{Hongjun2025,
  author = {Hongjun, Peng and Mukanhaire, Lydia and Zhen, Liu and Ting, Wang and Hongye, Li and Xiaotian, Zhang and Guangling, Liu and Xianguo, Ren},
  title = {LncRNA UCA1 regulates immune micro-environment in cisplatin-induced AKI by miRNA-4498/AKT3 pathway},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0314654}
}
Kostenlos starten →